关注
Lauren R Violette
Lauren R Violette
Research Fellow, Harvard Medical School, Harvard Pilgrim Health Care Institute
在 uw.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial
PK Drain, J Dorward, LR Violette, J Quame-Amaglo, KK Thomas, ...
The lancet HIV 7 (4), e229-e237, 2020
1012020
Doxycycline prophylaxis to prevent sexually transmitted infections in women
J Stewart, K Oware, D Donnell, LR Violette, J Odoyo, OO Soge, ...
New England Journal of Medicine 389 (25), 2331-2340, 2023
542023
Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study
M Sharma, E Mudimu, K Simeon, A Bershteyn, J Dorward, LR Violette, ...
The lancet HIV 8 (4), e216-e224, 2021
292021
Development of a targeted educational intervention to increase pre-exposure prophylaxis uptake among cisgender men and transgender individuals who have sex with men and use …
VM McMahan, A Martin, L Garske, LR Violette, MP Andrasik, JM Baeten, ...
Sexual health 16 (2), 139-147, 2019
222019
Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label …
J Stewart, E Bukusi, FA Sesay, K Oware, D Donnell, OO Soge, C Celum, ...
Trials 23 (1), 495, 2022
212022
Repeated false-positive HIV test results in a patient taking HIV pre-exposure prophylaxis
JD Stekler, LR Violette, L Niemann, VM McMahan, DA Katz, JM Baeten, ...
Open forum infectious diseases 5 (9), ofy197, 2018
152018
Heroin pipe distribution to reduce high-risk drug consumption behaviors among people who use heroin: a pilot quasi-experimental study
T Fitzpatrick, VM McMahan, ND Frank, SN Glick, LR Violette, S Davis, ...
Harm Reduction Journal 19 (1), 103, 2022
142022
Performance evaluation of four point-of-care HIV tests using unprocessed specimens
PR Chavez, HM Bradley, LG Wesolowski, LR Violette, DA Katz, ...
Journal of Clinical Virology 124, 104282, 2020
132020
Group sex events among cisgender men who have sex with men: cross-sectional and longitudinal survey study to explore participation and risk-taking behaviors
LR Violette, LA Niemann, VM McMahan, DA Katz, PR Chavez, HA Clark, ...
JMIR Research Protocols 8 (11), e15426, 2019
122019
‘I make sure my doctor doesn’t know that I use meth’: perceived barriers to pre-exposure prophylaxis (PrEP) uptake among community peer educators in Seattle (WA, USA)
VM McMahan, LR Violette, MP Andrasik, A Martin, L Garske, JD Stekler
Sexual health 17 (1), 29-37, 2019
112019
Protocol development for HMU!(HIV prevention for methamphetamine users), a study of peer navigation and text messaging to promote pre-exposure prophylaxis adherence and …
VM McMahan, N Frank, S Buckler, LR Violette, JM Baeten, ...
JMIR formative research 4 (9), e18118, 2020
82020
Prospective evaluation of HIV testing technologies in a clinical setting: protocol for Project DETECT
JD Stekler, LR Violette, HA Clark, SJ McDougal, LA Niemann, DA Katz, ...
JMIR Research Protocols 9 (1), e16332, 2020
82020
Self-reported Adherence to Event--driven Doxycycline Postexposure Prophylaxis for Sexually Transmitted Infection Prevention Among Cisgender Women
J Stewart, K Oware, D Donnell, LR Violette, J Odoyo, J Simoni, V Omollo, ...
SEXUALLY TRANSMITTED DISEASES 51 (1), S29-S30, 2024
62024
Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention
K Oware, L Adiema, B Rono, LR Violette, RS McClelland, D Donnell, ...
BMC Women's Health 23 (1), 296, 2023
62023
Point-Of-Care HIV viral load testing combined with task shifting to improve treatment outcomes: an open-label non-inferiority randomized controlled trial to simplify HIV …
PK Drain, J Dorward, LR Violette, J Quame-Amaglo, KK Thomas, ...
Lancet HIV, 2019
52019
Delivery of community-based antiretroviral therapy to maintain viral suppression and retention in care in South Africa
M Wang, LR Violette, J Dorward, H Ngobese, Y Sookrajh, E Bulo, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 93 (2), 126-133, 2023
42023
Challenges recruiting and retaining people at risk for HIV who use methamphetamine in a randomized PrEP adherence trial in Seattle, WA
VM McMahan, DL Atkins, S Buckler, LR Violette, L Niemann, N Frank, ...
International journal of STD & AIDS, 09564624241244835, 2024
22024
Efficient Expansion of a Behavioral Survey to Assess Sex, Gender, and Behavioral Risk Among Transgender and Nonbinary Individuals: HMU!(H IV Prevention for M ethamphetamine U sers)
N Frank, VM McMahan, LR Violette, A Martin, SN Glick, JD Stekler
Transgender Health 8 (5), 472-476, 2023
22023
Seroconversion, seroreversion, and serowaffling among participants initiating antiretroviral therapy in Project DETECT
JD Stekler, LR Violette, LA Niemann, VM McMahan, DA Katz, PR Chavez, ...
International journal of STD & AIDS 34 (6), 385-394, 2023
22023
Evaluation of SAMBA II: a qualitative and semiquantitative HIV point-of-care nucleic acid test
LR Violette, A Cornelius-Hudson, M Snidarich, LA Niemann, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 89 (5), 537-545, 2022
22022
系统目前无法执行此操作,请稍后再试。
文章 1–20